Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Double-blind Randomized Placebo-controlled Multicenter Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects with Heart Failure and Left Ventricular Systolic Dysfunction

i to select an oral modified release MR formulation and dose of omecamtiv mecarbil for chronic twice daily BID dosing in subjects with HF and left ventricular systolic dysfunction and ii to characterize its pharmacokinetics PK over 20 weeks of treatment

FieldValue
Modified
2019-08-29
Release Date
2018-03-23
Identifier
32871d16-9709-41a9-a3f5-a2a20f949cb9
License
Public Access Level
Public